Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF

针对人类新鲜血液和血清样本的靶向 1H NMR 代谢组学和免疫表型分析可区分健康个体和接受抗 TNF 治疗的炎症性肠病患者